Larimar Therapeutics is led by Dr. Carole Ben-Maimon, MD, who serves as the President and Chief Executive Officer of the clinical-stage biotechnology enterprise. Bringing extensive leadership experience in the pharmaceutical and rare disease therapeutic sectors, she guides the company's strategic corporate direction, regulatory interactions with health authorities like the FDA, and the clinical advancement of its innovative pipeline focused on complex rare diseases.